Literature DB >> 16098461

Metastasis gets site specific.

Christine E Horak1, Patricia S Steeg.   

Abstract

Organ-specific homing and colonization of cancer cells are important and interesting features of metastasis. Molecular programs that contribute to this tropism may be elucidated through gene expression profiling with DNA microarrays. Using experimentally derived breast cancer cells that home specifically to bone or to lung, several investigators have concluded that distinct alterations in gene expression underlie metastasis to these sites. Minn et al. (2005) report a set of genes involved in lung-specific metastasis of breast cancer; the authors have determined the functional contribution of several genes to the metastatic cascade, as well as the relevance of these genes to human disease.

Entities:  

Mesh:

Year:  2005        PMID: 16098461     DOI: 10.1016/j.ccr.2005.07.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  12 in total

1.  Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems.

Authors:  M Cecilia Subauste; Tatyana A Kupriyanova; Erin M Conn; Veronica C Ardi; James P Quigley; Elena I Deryugina
Journal:  Clin Exp Metastasis       Date:  2009-10-20       Impact factor: 5.150

2.  Mechanisms regulating colorectal cancer cell metastasis into liver (Review).

Authors:  Ketao Jin; Weili Gao; Yanyan Lu; Huanrong Lan; Lisong Teng; Feilin Cao
Journal:  Oncol Lett       Date:  2011-09-30       Impact factor: 2.967

3.  Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Jian He; Hai-Ying Zeng; Xiao-Dong Zhu
Journal:  Oncologist       Date:  2011-06-10

4.  A clinicopathological model to predict bone metastasis in hepatocellular carcinoma.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Jia Fan; Wei-Zhong Wu; Jian He; Hai-Ying Zeng; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-14       Impact factor: 4.553

5.  Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.

Authors:  Steven Christopher Smith; Brian Nicholson; Matthew Nitz; Henry F Frierson; Mark Smolkin; Garret Hampton; Wael El-Rifai; Dan Theodorescu
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

6.  Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.

Authors:  Julie M Wu; Mary Jo Fackler; Marc K Halushka; Diana W Molavi; M Evangeline Taylor; Wei Wen Teo; Constance Griffin; John Fetting; Nancy E Davidson; Angelo M De Marzo; Jessica L Hicks; Dhananjay Chitale; Marc Ladanyi; Saraswati Sukumar; Pedram Argani
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

Review 7.  Anti-metastatic functions of type 1 interferons: Foundation for the adjuvant therapy of cancer.

Authors:  Angélica Ortiz; Serge Y Fuchs
Journal:  Cytokine       Date:  2016-01-25       Impact factor: 3.861

8.  Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.

Authors:  N Voorzanger-Rousselot; F Juillet; E Mareau; J Zimmermann; T Kalebic; P Garnero
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

9.  Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues.

Authors:  Carol D Curtis; Daniel L Thorngren; Ann M Nardulli
Journal:  BMC Cancer       Date:  2010-01-11       Impact factor: 4.430

10.  Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Peng-Yuan Zhuang; Ying Liang; Yun-Shan Tan; Jian He
Journal:  BMC Cancer       Date:  2009-06-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.